Navigator

      Support By : Li-lab

Drugs And Genes
Negative Drug Target Genes
GENE_SYMBOL DRUG_NAME Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) Potency (nM) AC50 (nM) Datasource
SELE (S)-4-Methylcarbamoyl-4-[(R)-2-(2-tetradecyl-hexadecanoylamino)-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propionylamino]-butyric acid methyl ester NA 500000 NA NA NA NA TTD
SELE 2-[(R)-2-(2-Tetradecyl-hexadecanoylamino)-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propionylamino]-pentanedioic acid 1-methyl ester NA 500000 NA NA NA NA TTD
SELE 4-[(R)-2-Hexadecanoylamino-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propionylamino]-4-methylcarbamoyl-butyric acid NA 500000 NA NA NA NA TTD
SELE sodium;(2S)-2-[2-carbamoyl-3,5-dihydroxy-6-[2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxyoxan-4-yl]oxy-3-cyclohexylpropanoate NA 10000000 NA NA NA NA TTD
SELE Sodium;2-[2-(acetamidomethyl)-3,5-dihydroxy-6-[2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxyoxan-4-yl]oxy-3-phenylpropanoate NA 10000000 NA NA NA NA TTD
SELE Sodium;2-[2-(benzamidomethyl)-3,5-dihydroxy-6-[2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxycyclohexyl]oxyoxan-4-yl]oxy-3-phenylpropanoate NA 10000000 NA NA NA NA TTD
SELE (S)-2-{[2''-(3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-biphenyl-3-carbonyl]-amino}-pentanedioic acid NA 15800000 NA NA NA NA BindingDB
SELE (S)-3-Phenyl-2-{[2''-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-biphenyl-4-carbonyl]-amino}-propionic acid NA 3800000 NA NA NA NA BindingDB
SELE sodium;[(2S,3R,4R,5R,6R)-6-[(2R,3S,4R,5S)-5-acetamido-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-2,4,5-trihydroxyoxan-3-yl] sulfate NA 1000000 NA NA NA NA TTD
SELE 5-(2-{2-[5-Acetylamino-2-hydroxymethyl-4-(2,3,4-trihydroxy-5-methoxy-hexyloxy)-tetrahydro-pyran-3-yloxy]-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-4-yloxy}-acetylamino)-2,4-dihydroxy-6-(1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid NA 1000000 NA NA NA NA TTD
SELE sodium;[(2S,3R,4R,5R,6R)-2,4,5-trihydroxy-6-[(2R,3S,4R)-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxyoxan-3-yl] hydrogen phosphate NA 1000000 NA NA NA NA TTD
SELE 5-(2-{3,5-Dihydroxy-2-hydroxymethyl-6-[2-hydroxymethyl-4-(2,3,4-trihydroxy-5-methoxy-hexyloxy)-tetrahydro-pyran-3-yloxy]-tetrahydro-pyran-4-yloxy}-acetylamino)-2,4-dihydroxy-6-(1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid NA 240000 NA NA NA NA BindingDB|TTD
SELE 5-Acetylamino-2-{3,5-dihydroxy-2-hydroxymethyl-6-[2-hydroxymethyl-4-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yloxy]-tetrahydro-pyran-4-yloxy}-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid NA 360000 NA NA NA NA BindingDB|TTD
SELE sodium;[(2S,3R,4R,5R,6R)-2,4,5-trihydroxy-6-[(2R,3R,4R,5S)-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxyoxan-3-yl] sulfate NA 1000000 NA NA NA NA TTD
SELE sodium;[(2S,3R,4R,5R,6R)-2,4,5-trihydroxy-6-[(2R,3S,4R)-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxyoxan-3-yl] sulfate NA 1000000 NA NA NA NA TTD
SELE 4-[((3R,5R)-1,3,4,5-Tetrahydroxy-cyclohexanecarbonyl)-amino]-butyric acid NA 50000000 NA NA NA NA TTD
SELE 6-[((R)-(R)-1,3,4,5-Tetrahydroxy-cyclohexanecarbonyl)-amino]-hexanoic acid NA 50000000 NA NA NA NA TTD
SELE ((3R,5R)-1,3,4,5-Tetrahydroxy-cyclohexanecarbonyl)-carbamic acid NA 50000000 NA NA NA NA TTD
SELE (S)-2-[((3R,5R)-1,3,4,5-Tetrahydroxy-cyclohexanecarbonyl)-amino]-pentanedioic acid NA 50000000 NA NA NA NA TTD
SELE [alpha-Neu5Ac-(2,3)-beta-D-Gal-(1,4) (alpha-Fuc-(1,3))-D-Glc] NA 700000 NA NA NA NA BindingDB